Dongsung Pharmaceutical Improvement Period Ends, Delisting Review Process Begins
-
Dongsung Pharmaceutical's improvement period ended (May 13, 2026): delisting review process to proceed
-
Deadline for submitting improvement plan implementation report: by May 22, 2026
-
Korea Exchange to hold Corporate Review Committee within 20 business days after submission to decide on delisting
KOSPI Filing Information
-
Filing: Other Market Notice (End of Improvement Period and Guidance on Future Procedures)
-
Company: Dongsung Pharmaceutical (002210)
-
Submission: Securities Market Division
-
Receipt: 05-13-2026
-
Under KRX KOSPI Market Division